🔗 Share this article Texas Attorney General Takes Legal Action Against Acetaminophen Producers Regarding Autism Spectrum Allegations The Texas Attorney General, a Trump ally who is running for the United States Senate, alleged the drug companies of concealing safety concerns of acetaminophen The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of Tylenol, asserting the firms hid potential risks that the medication presented to children's brain development. This legal action comes a month after Donald Trump publicized an unverified association between using Tylenol - referred to as paracetamol - throughout gestation and autism spectrum disorder in young ones. The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which presently makes it. In a official comment, he said they "deceived the public by profiting off of discomfort and pushing pills regardless of the potential hazards." Kenvue says there is no credible evidence tying acetaminophen to autism. "These companies misled for generations, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, declared. Kenvue stated officially that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the welfare of American women and children." On its official site, the company also said it had "regularly reviewed the applicable studies and there is no credible data that shows a verified association between taking paracetamol and autism." Organizations representing medical professionals and medical practitioners concur. The American College of Obstetricians and Gynecologists has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to treat pain and elevated temperature, which can create major wellness concerns if ignored. "In multiple decades of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has successfully concluded that the consumption of paracetamol in any stage of pregnancy leads to neurodevelopmental disorders in offspring," the association said. The court filing cites current declarations from the previous government in asserting the medication is allegedly unsafe. In recent weeks, the former president generated worry from health experts when he advised expectant mothers to "resist strongly" not to consume acetaminophen when ill. The US Food and Drug Administration then released a statement that physicians should think about restricting the consumption of Tylenol, while also stating that "a proven link" between the medication and autism in young ones has not been proven. Health Secretary Kennedy, who oversees the Food and Drug Administration, had pledged in spring to undertake "extensive scientific investigation" that would establish the source of autism in a matter of months. But specialists warned that discovering a sole reason of autism - thought by researchers to be the result of a intricate combination of genetic and environmental factors - would prove challenging. Autism spectrum disorder is a category of enduring cognitive variation and impairment that impacts how persons perceive and interact with the environment, and is recognized using medical professional evaluations. In his lawsuit, Paxton - who supports Trump who is seeking US Senate - claims the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the research" around paracetamol and autism. The lawsuit attempts to require the corporations "destroy any promotional materials" that asserts Tylenol is secure for pregnant women. The Texas lawsuit parallels the concerns of a collection of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in 2022. The court rejected the lawsuit, stating studies from the parents' expert witnesses was not conclusive.